Situation profile

Macular degeneration: protecting sight from both disease and clinics

This is a composite decision situation, not a real patient, testimonial or individual treatment recommendation.

Macular degeneration: protecting sight from both disease and clinics

The letters on the chart keep shrinking on one side, injections into the eye have become routine, and the fear underneath is specific: the centre of vision going dark. That fear has a market. Eye clinics selling “stem cell” injections have produced some of the field's most documented harm — and, separately, some of its most legitimate science.

What the data says for this situation

Registry snapshot (2026-08-29): MSC studies: 4 (2 recruiting) · HSCT-family: 1 · exosomes: 1. Source: ClinicalTrials.gov API v2.

Both extremes live here. Legitimate: embryonic and iPSC-derived retinal-pigment-epithelium programmes — 44 studies across cell types in our snapshot (4 MSC, mostly the specialised RPE work) — carefully transplanting engineered tissue in regulated trials, with encouraging early safety and hints of stabilisation. Catastrophic: US clinics that injected adipose “stem cells” into eyes blinded patients, producing the field's most cited harm cases and regulator crackdowns. The difference is not subtle: engineered retinal tissue in trials versus fat-derived slurry sold for cash. Any commercial offer to inject cells into or near your eye deserves maximal suspicion.

Questions worth asking any provider

  1. Is this an RPE-lineage product in a registered ophthalmology trial?
  2. Who is the retinal surgeon, and what is the centre's published record?
  3. Wet or dry AMD — and does the cited research match mine?
  4. What monitoring detects harm early?

Red flags specific to this situation

  • Adipose or IV 'stem cells' offered for any eye disease
  • Same-day bilateral injections (the blinded-patients pattern)
  • Any eye offer outside a registered trial

Cost context

Legitimate retinal-cell therapy is trial-access only. Commercial eye injections have no approved basis at any price — and documented catastrophic downside.

FAQ

Is there a stem cell cure for macular degeneration?

No. Regulated RPE-transplant trials show early promise; commercial injections have caused documented blindness.

How do I find legitimate trials?

Registered ophthalmology programmes list on ClinicalTrials.gov — our checklist helps verify a real one.

→ Build questions for a specific provider · → Cost calculator

Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads